Merck Exec Says 'We Have Every Indication That The National Priority Voucher Given For Enlicitide Is Moving Forward'; Says 'We Are Interested In Looking At The Broader Obesity Space, But Less About Obesity Than Its Comorbidities'

Merck Exec Says 'We Have Every Indication That The National Priority Voucher Given For Enlicitide Is Moving Forward'; Says 'We Are Interested In Looking At The Broader Obesity Space, But Less About Obesity Than Its Comorbidities'